MarketWatch News on MTNB
No News currently available for MTNB
Advertisement
Other News on MTNB
10-Q: MATINAS BIOPHARMA HOLDINGS, INC. 12:17 p.m. Nov. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Press Releases on MTNB
Matinas BioPharma Commences Dosing in First Human Trial of Lead Product Candidate MAT9001 7:36 a.m. Nov. 12, 2014 - GlobeNewswire
Matinas Biopharma Receives Notice of Allowance of U.S. Patent for MAT9001 7:36 a.m. Nov. 10, 2014 - GlobeNewswire
Matinas BioPharma Appoints Cardiologist and Lipidology Expert Christie M. Ballantyne, M.D. to Scientific Advisory Board 7:35 a.m. Nov. 4, 2014 - GlobeNewswire
Matinas BioPharma Receives Authorization From Health Canada to Initiate Human Clinical Study of Lead Product Candidate MAT9001 6:36 a.m. Oct. 29, 2014 - GlobeNewswire
Matinas BioPharma Submits Investigational New Drug Application for Lead Product Candidate MAT9001 for the Treatment of Severe Hypertriglyceridemia 7:06 a.m. Oct. 20, 2014 - GlobeNewswire
Matinas BioPharma to Present at the 13th Annual BIO Investor Forum on Wednesday, October 8, 2014 6:35 a.m. Sept. 30, 2014 - GlobeNewswire
Matinas BioPharma - "Clinical Treatment Guidelines for Dyslipidemia Continue to Evolve" 9:31 a.m. Sept. 29, 2014 - ACCESSWIRE
Matinas BioPharma Holdings, Inc. Approved to Trade on OTCQB Venture Stage Marketplace 6:06 a.m. Sept. 8, 2014 - GlobeNewswire
Matinas BioPharma to Present at Three Investor Conferences in September 6:05 a.m. Sept. 4, 2014 - GlobeNewswire
S&P Capital IQ Initiates Coverage on Matinas BioPharma Holdings, Inc. in S&P Capital IQ Factual Stock Reports 8:38 a.m. Sept. 3, 2014 - PR Newswire - PRF
Matinas BioPharma - "Lipidomics - An Exciting Foundation for Matinas BioPharma" 8:28 a.m. Aug. 6, 2014 - ACCESSWIRE
Matinas BioPharma Launches Digital Corporate Communication Channels 7:10 a.m. July 31, 2014 - GlobeNewswire
Matinas BioPharma Holdings, Inc. Common Stock Commences Trading on OTCBB Under Ticker Symbol MTNB 7:16 a.m. July 22, 2014 - Marketwire